FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....